vs

Side-by-side financial comparison of SOLAI Ltd (SLAI) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.

Sol-Gel Technologies Ltd. is the larger business by last-quarter revenue ($17.3M vs $11.0M, roughly 1.6× SOLAI Ltd). Sol-Gel Technologies Ltd. runs the higher net margin — 67.3% vs -126.2%, a 193.5% gap on every dollar of revenue. On growth, Sol-Gel Technologies Ltd. posted the faster year-over-year revenue change (217.7% vs -43.1%).

Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.

SLAI vs SLGL — Head-to-Head

Bigger by revenue
SLGL
SLGL
1.6× larger
SLGL
$17.3M
$11.0M
SLAI
Growing faster (revenue YoY)
SLGL
SLGL
+260.8% gap
SLGL
217.7%
-43.1%
SLAI
Higher net margin
SLGL
SLGL
193.5% more per $
SLGL
67.3%
-126.2%
SLAI

Income Statement — Q2 FY2025 vs Q2 FY2025

Metric
SLAI
SLAI
SLGL
SLGL
Revenue
$11.0M
$17.3M
Net Profit
$-13.9M
$11.6M
Gross Margin
0.1%
Operating Margin
-126.2%
65.1%
Net Margin
-126.2%
67.3%
Revenue YoY
-43.1%
217.7%
Net Profit YoY
-173.4%
487.6%
EPS (diluted)
$-0.01
$4.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SLAI
SLAI
SLGL
SLGL
Q2 25
$11.0M
$17.3M
Q2 24
$19.4M
$5.4M
Q2 23
$594.0K
Q2 22
$3.5M
Net Profit
SLAI
SLAI
SLGL
SLGL
Q2 25
$-13.9M
$11.6M
Q2 24
$18.9M
$2.0M
Q2 23
$-6.0M
Q2 22
$-134.0K
Gross Margin
SLAI
SLAI
SLGL
SLGL
Q2 25
0.1%
Q2 24
52.4%
Q2 23
Q2 22
Operating Margin
SLAI
SLAI
SLGL
SLGL
Q2 25
-126.2%
65.1%
Q2 24
-2.6%
29.9%
Q2 23
-1098.8%
Q2 22
-13.2%
Net Margin
SLAI
SLAI
SLGL
SLGL
Q2 25
-126.2%
67.3%
Q2 24
97.9%
36.4%
Q2 23
-1005.1%
Q2 22
-3.8%
EPS (diluted)
SLAI
SLAI
SLGL
SLGL
Q2 25
$-0.01
$4.17
Q2 24
$0.02
$0.71
Q2 23
$-0.22
Q2 22
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SLAI
SLAI
SLGL
SLGL
Cash + ST InvestmentsLiquidity on hand
$1.2M
$24.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$43.8M
$31.9M
Total Assets
$69.1M
$39.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SLAI
SLAI
SLGL
SLGL
Q2 25
$1.2M
$24.3M
Q2 24
$2.3M
$26.5M
Q2 23
$33.5M
Q2 22
$15.6M
Stockholders' Equity
SLAI
SLAI
SLGL
SLGL
Q2 25
$43.8M
$31.9M
Q2 24
$45.9M
$34.9M
Q2 23
$48.3M
Q2 22
$50.4M
Total Assets
SLAI
SLAI
SLGL
SLGL
Q2 25
$69.1M
$39.3M
Q2 24
$63.3M
$42.0M
Q2 23
$55.1M
Q2 22
$55.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SLAI
SLAI
SLGL
SLGL
Operating Cash FlowLast quarter
$-17.0M
Free Cash FlowOCF − Capex
$-17.0M
FCF MarginFCF / Revenue
-154.2%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SLAI
SLAI
SLGL
SLGL
Q2 25
$-17.0M
Q2 24
$-12.1M
Q2 23
$-8.3M
Q2 22
Free Cash Flow
SLAI
SLAI
SLGL
SLGL
Q2 25
$-17.0M
Q2 24
Q2 23
$-8.4M
Q2 22
FCF Margin
SLAI
SLAI
SLGL
SLGL
Q2 25
-154.2%
Q2 24
Q2 23
-1419.0%
Q2 22
Capex Intensity
SLAI
SLAI
SLGL
SLGL
Q2 25
0.0%
Q2 24
Q2 23
15.8%
Q2 22
Cash Conversion
SLAI
SLAI
SLGL
SLGL
Q2 25
Q2 24
-0.64×
Q2 23
Q2 22

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SLAI
SLAI

Data center$6.5M59%
Cryptocurrency mining$4.6M41%

SLGL
SLGL

Segment breakdown not available.

Related Comparisons